Galena Biopharma Launches Anti-Nausea Drug Zuplenz
Shares of Galena Biopharma (GALE) are up 5% after the company announced that it has launched its anti-nausea drug known as Zuplenz . Zuplenz is an oral soluble film that helps reduce nausea and vomiting in patients with:
- Chemotherapy-induced nausea and vomiting -- CINV
- Radiotherapy-induced nausea and vomiting -- RINV
- Post-operative nausea and vomiting -- PONV
Zuplenz is a bioequivalent to odanestron -- a similar product that also reduces nausea and vomiting. The drug product from Galena is now available worldwide and will be available at two dose levels, 4 mg and 8 mg. The benefits, as per the press release Galena released today:
- Rapidly dissolves in the mouth in about 10 seconds
- Eliminates the burden of swallowing pills during emesis and in cases of oral irritation
- Does not require water to administer
- Pleasant peppermint flavor with no gritty aftertaste
- Non-sedating
Zuplenz technology uses a type of FarmFilm technology that allows the soluble film to dissolve in the patient's mouth. The film dissolves in about 10 seconds or less.
Disclosure: None.
Any updates?
How do you think this will impact the stock price? Or rather, by how much?